Dovato (Dolutegravir Sodium And Lamivudine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dovato. Always confirm against the full prescribing information.
100 interactions
Abatacept
The risk or severity of liver damage can be increased when Lamivudine is combined with Abatacept.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Abatacept is combined with Dolutegravir.
Level 2 evidence
Abemaciclib
Abemaciclib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Level 2 evidence
Abemaciclib
Abemaciclib may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Lamivudine is combined with Abiraterone.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Dolutegravir.
Level 2 evidence
Abrocitinib
The serum concentration of Dolutegravir can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Lamivudine is combined with Acalabrutinib.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Dolutegravir is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Lamivudine.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Dolutegravir.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Dolutegravir.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Lamivudine.
Dovato (Dolutegravir Sodium And Lamivudine) has 2121 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Dovato (Dolutegravir Sodium And Lamivudine) has 17 major, 1895 moderate, and 209 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Dovato. Always confirm against the full prescribing information.